EUVIMEDEUVIMED entdecken
Crossref

Scalable and Uniform Fabrication of Dexamethasone-Eluting Depot-Engineered Stem Cell Spheroids as a Microtissue Construct to Target Bone Regeneration

Tiep Tien Nguyen, Mai Thi Phuong, Manju Shrestha, Junhyeung Park, Pham Le Minh, Jong Oh Kim iD, Hyukjae Choi, Joo-Won Nam iD, Hu-Lin Jiang, Hyung-Sik Kim, Jee-Heon Jeong iD, Jun-Beom Park und 1 weitere

ACS Applied Materials & Interfaces · 2023

DOI: 10.1021/acsami.3c03102 ↗

Kurz gefasst

Fachartikel in der Zeitschrift ACS Applied Materials & Interfaces, 2023. Verfasst von Tiep Tien Nguyen und 12 weiteren Autor:innen. Beteiligte Einrichtung: College of Pharmacy, Keimyung University, Daegu 42601, Republic of Korea. Hauptthemen laut MEDLINE: Spheroids, Cellular, Mesenchymal Stem Cells. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 55 Literaturangaben. Gefördert von: Ministry of Health and Welfare, Ministry of Science and ICT, South Korea, National Research Foundation of Korea.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Spheroids, CellularMesenchymal Stem CellsMiceAnimalsOsteogenesisBone RegenerationCell DifferentiationTissue EngineeringDexamethasone

Stichwörter der Autor:innen

dexamethasonemesenchymal stem cell spheroidmicroparticlemicrotissue engineeringpolydopamine

Substanzen

Dexamethasone

Autor:innen und Institutionen

  • College of Pharmacy, Keimyung University, Daegu 42601, Republic of Korea.
  • College of Pharmacy, Yeungnam University, Gyeongsan 38541, Gyeongbuk, Republic of Korea.
  • Department of Precision Medicine, School of Medicine, Sungkyunkwan University, Suwon 16419, Republic of Korea.
  • State Key Laboratory of Natural Medicines, China Pharmaceutical University, Nanjing 210009, China.
  • Jiangsu Key Laboratory of Druggability of Biopharmaceuticals, China Pharmaceutical University, Nanjing 210009, China.
  • Jiangsu Key Laboratory of Drug Discovery for Metabolic Diseases, China Pharmaceutical University, Nanjing 210009, China.

ORCID-Profile: Jong Oh Kim, Joo-Won Nam, Jee-Heon Jeong, Simmyung Yook

Förderung

  • Ministry of Health and Welfare
  • Ministry of Science and ICT, South Korea
  • National Research Foundation of Korea

Zitieren

APA

Nguyen, T. T., Phuong, M. T., Shrestha, M., Park, J., Le Minh, P., Kim, J. O., Choi, H., Nam, J. W., Jiang, H. L., Kim, H. S., Jeong, J. H., Park, J. B., & Yook, S. (2023). Scalable and Uniform Fabrication of Dexamethasone-Eluting Depot-Engineered Stem Cell Spheroids as a Microtissue Construct to Target Bone Regeneration. ACS Applied Materials & Interfaces. https://doi.org/10.1021/acsami.3c03102

Vancouver

Nguyen TT, Phuong MT, Shrestha M, Park J, Le Minh P, Kim JO, et al. Scalable and Uniform Fabrication of Dexamethasone-Eluting Depot-Engineered Stem Cell Spheroids as a Microtissue Construct to Target Bone Regeneration. ACS Applied Materials & Interfaces. 2023. doi:10.1021/acsami.3c03102

BibTeX
@article{Nguyen2023,
  author = {Nguyen, Tiep Tien and Phuong, Mai Thi and Shrestha, Manju and Park, Junhyeung and Le Minh, Pham and Kim, Jong Oh and Choi, Hyukjae and Nam, Joo-Won and Jiang, Hu-Lin and Kim, Hyung-Sik and Jeong, Jee-Heon and Park, Jun-Beom and Yook, Simmyung},
  title = {Scalable and Uniform Fabrication of Dexamethasone-Eluting Depot-Engineered Stem Cell Spheroids as a Microtissue Construct to Target Bone Regeneration},
  journal = {ACS Applied Materials & Interfaces},
  year = {2023},
  doi = {10.1021/acsami.3c03102}
}
Kostenlos starten →